Selected Grants
Specialty versus Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia
Clinical TrialPrincipal Investigator · Awarded by Massachusetts General Hospital · 2022 - 2031realMIND: A multicenter, observational study to characterize the safety and effectiveness of tafasitamab in combination with lenalidomide in US patients with relapsed or refractory diffuse large B-cell lymphoma with a focus on racial and ethnic minor
Clinical TrialPrincipal Investigator · Awarded by Incyte Corporation · 2025 - 2030Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2024 - 2029Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2024 - 2029Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029Barriers and Pathways: A Comprehensive Study on Return-to-Work for Hematopoietic Cell Transplantation Survivors
ResearchMentor · Awarded by American Society of Hematology · 2025 - 2028Patient Experience Research and Palliative Care Integration in Malignant Hematology
ResearchPrincipal Investigator · Awarded by Leukemia & Lymphoma Society · 2022 - 2027Deverra: Phase 1:DVX201 NK cells in R/R AML High risk MDS or Myeloproliferative Neoplasms
Clinical TrialPrincipal Investigator · Awarded by Deverra Therapeutics · 2021 - 2026Experience of Veterans with Myeloproliferative Neoplasms
ResearchMentor · Awarded by American Society of Clinical Oncology · 2025 - 2026Racial and Ethnic Differences in the Real-World Clinical Outcomes of IDH1 and IDH2 Inhibitors in Acute Myeloid Leukemia
ResearchMentor · Awarded by University of North Carolina - Chapel Hill · 2024 - 2026Exploring the impact of conditioning regimen selection on clinical outcomes and quality of life in
ResearchMentor · Awarded by American Society of Hematology · 2024 - 2026Determinants of Palliative Care Effectiveness for Patients with Cancer
ResearchPrincipal Investigator · Awarded by University of Colorado Anschutz Medical Campus · 2024 - 2026JZP351-502 V-RULES: Vyxeos Real-world US Long-term Effectiveness and Safety Study
ResearchPrincipal Investigator · Awarded by Jazz Pharmaceuticals · 2024 - 2025Real-World Analysis of Belantamab Mafodotin Dosing Patterns in Patients with Relapsed and/or Refractory Multiple Myeloma
ResearchPrincipal Investigator · Awarded by GlaxoSmithKline · 2023 - 2025Specialty versus Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia (SCOPE-Leukemia): Comparative Effectiveness Trial
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2022 - 2025Disco Thermometer Engineering Study Protocol No.: 60117201
Clinical TrialPrincipal Investigator · Awarded by Welch Allyn, Inc. · 2024 - 2025Real World Treatment Experience of Patients with Acute Myelogenous Leukemia Using Remote Symptom Monitoring
ResearchPrincipal Investigator · Awarded by Carevive Systems, Inc. · 2021 - 2024Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training
ResearchCo Investigator · Awarded by Dana-Farber Cancer Institute · 2018 - 2024NAVIGATE- DreAMLand
Clinical TrialPrincipal Investigator · Awarded by Massachusetts General Hospital · 2022 - 2024Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2023Evaluating physical functioning using patient-reported outcome measures: How does the question form and recall period influence patients' interpretation?
ResearchCo Investigator · Awarded by Food and Drug Administration · 2020 - 2023Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2018 - 2023Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives
ResearchPrincipal Investigator · Awarded by University of Pittsburgh · 2021 - 2023Palliative Care Research Cooperative Group (PCRC) Refinement and Expansion
ResearchChair · Awarded by University of Colorado - Denver · 2018 - 2023Mindfulness and Cognitive Behavioral Therapy for Sleep in Cancer
FellowshipCo-Mentor · Awarded by National Institutes of Health · 2021 - 2023A mixed-methods study of the nature, extent and consequences of atificial intelligence (AI) for individualized treatment planning in end-of-life and palliative care (EOLPC)
ResearchPrincipal Investigator · Awarded by University of Colorado Anschutz Medical Campus · 2022 - 2023Testing a Nurse-Led Evidence-Based Exercise Program to Improve Patient-Reported Outcomes in Adults with Acute Leukemia
ResearchSignificant Contributor · Awarded by Oncology Nursing Society Foundation · 2020 - 2022"Understanding the Patient Experience of Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC) in the Immuno-oncology Era"
ResearchPrincipal Investigator · Awarded by AstraZeneca PLC · 2020 - 2022Symptom Burden and Quality of Life in Multiple Myeloma Patients
FellowshipMentor · Awarded by American Cancer Society, Inc. · 2019 - 2021Prognostic understanding and decision-making in acute myeloid leukemia (AML)
ResearchPrincipal Investigator · Awarded by American Cancer Society, Inc. · 2016 - 2021Advanced symptom burden and quality of life in multiple myeloma patients
FellowshipCollaborator · Awarded by National Institutes of Health · 2019 - 2021Treatment Switching Behavior among Multiple Myeloma Patients
ResearchKey Faculty · Awarded by Amgen, Inc. · 2018 - 2021AC220-A-U302 trial
Clinical TrialPrincipal Investigator · Awarded by Daiichi Sankyo Inc · 2016 - 2020Understanding Barriers to Oral Therapy Adherence in Adult/Older-Adult AML Patients (429 Oral)
ResearchPrincipal Investigator · Awarded by Carevive Systems, Inc. · 2019 - 2019Caregiver-Guided Pain Management Training in Palliative Care
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2019Palliative care and shared decision-making for patients with blood cancers
ResearchPrincipal Investigator · Awarded by Cambia Health Foundation · 2015 - 2018Refinement and Expansion of the Palliative Care Research Cooperative Group
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2018TRIADIC EXPECTATIONS: DECISION-MAKING IN ADVANCED CANCER
ResearchSignificant Contributor · Awarded by National Palliative Care Research Center · 2014 - 2017Prognostic Discordance in Oncology: what's behind the misunderstanding?
ResearchPrincipal Investigator · Awarded by National Palliative Care Research Center · 2013 - 2015External Relationships
- AbbVie, Inc.
- American Cancer Society
- Astellas Pharma Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- Daiichi Sankyo Co., Ltd
- Dosentrx
- Eli Lilly & Co.
- Genentech, Inc (Roche Holding)
- Geron Pharmaceuticals
- Gilead Sciences, Inc.
- GlaxoSmithKline
- Incyte
- Kura
- Menarini Stemline
- Novartis pharmaceuticals
- Novo Nordisk
- Pfizer Inc.
- Rigel Pharmaceuticals, Inc
- Servier Pharmaceuticals
- Syndax
- Taiho
- Thyme Care
- UpToDate, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.